Clinical Trial Update: Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a combined cytotoxic and immune-stimulatory therapy for malignant glioma, including glioblastoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Malignant Glioma, Glioblastoma Multiforme | Phase 1 | Status: COMPLETED